DrugPipeline.net has announced the addition of “Australia Market Report for Implantable Ports 2017 - MedCore” research report to their website DrugPipeline.net
Bangalore, Karnataka -- (SBWIRE) -- 03/02/2017 -- General Report Contents
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions
The implantable port market in Australia continues to experience moderate unit sales growth due to increasing implantations, mainly in chemotherapy patients. However, the growth in implantable ports has been tempered by the increasing usage of peripherally inserted central venous catheters (PICCs) in Australia. While clinical studies have shown that implantable ports are associated with lower complication rates than PICCs the costs associated with implanting PICCs is lower due to the fact that nursing staff are able to able to insert PICC lines and the procedure does not require an operating suite. Moreover, the unit cost per PICC is lower than that of implantable ports. Nonetheless, the use of implantable ports will continue and unit sales will increase over the forecast period. The ASP of the market will decline at a rate similar to the increase in unit sales due to the commoditization of the product and the wide range of products available on the market, resulting in the implantable port market becoming the fastest declining market in Australia.
The Australian market for implantable ports comprises conventional implantable ports and power-injectable implantable ports. Conventional implantable ports are defined as implantable ports that do not feature power-injection. The Australian market for implantable ports has been contracting due to a shift away from conventional and towards power-injectable implantable ports. This is further amplified as a result of strong declines in ASPs for power-injectable implantable ports as competitors are expecting strong growth for this segment.
Spanning over 439 pages "Australia Market Report for Implantable Ports 2017 - MedCore" report covers Executive Summary, Australia Vascular Access Device And Accessories Market Overview, Competitive Analysis, Research Methodology, Disease Overview, Product Assessment, Implantable Port Market, Appendix. The report covered companies are - C. R. Bard, Becton Dickinson, Teleflex, Smiths Medical, B. Braun, Cook Medical, Medcomp, Angiodynamics, Medtronic, Baxter
For more information Visit at: http://www.drugpipeline.net/idata-research/australia-market-report-implantable-ports-2017-medcore
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.